Gadoxetic Acid–enhanced Magnetic Resonance Imaging and Contrast-enhanced Ultrasonography in the Diagnosis of Hepatocellular Carcinoma
CCM Cho
Hong Kong J Radiol 2017;20:175-91
DOI: 10.12809/hkjr1716871
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and one of the leading causes of cancer-related deaths. Early diagnosis of HCC is crucial to achieve good outcome. Advances in imaging technology enable detection of early disease, accurate tumour staging, treatment planning, and posttreatment monitoring, as well as an update of management guidelines. This review focuses on the development of gadoxetic acid–enhanced magnetic resonance imaging and contrast-enhanced ultrasonography in the diagnosis of HCC.
Authors’ affiliations:
CCM Cho: Department of Imaging and Interventional Radiology, Prince of Wales Hospital, Shatin, Hong Kong
中文摘要
釓塞酸增強磁共振成像和超聲造影的肝癌診斷
曹子文
肝細胞癌是肝臟中最常見的原發性惡性腫瘤，是癌症相關死亡的主要原因之一。及時診斷肝細胞癌 是達至良好治療結果的關鍵。成像技術的進展有利於早期疾病檢測、準確腫瘤分期、治療計劃和治 療後的監測，以及對治療指引的更新。本文重點回顧釓塞酸增強磁共振成像和超聲造影在診斷肝癌 的進展。